Brief: Medexus Q3 Revenue Up 35%
Feb 8 (Reuters) - Medexus Pharmaceuticals Inc MDP.TO :
* MEDEXUS PHARMACEUTICALS INC Q3 REVENUE ROSE 35 PERCENT TO
$28.7
MILLION
* MEDEXUS ANNOUNCES ANOTHER RECORD QUARTER WITH FISCAL Q3
2023
REVENUE OF US$28.7 MILLION, A 35% INCREASE OVER FISCAL Q3 2022
* MEDEXUS PHARMACEUTICALS INC QTRLY NET LOSS OF $1.5
MILLION, A
YEAR-OVER-YEAR CHANGE OF $0.4 MILLION
Source text for Eikon: ID:nGNX18lCR5
Further company coverage: MDP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million